- Home
- CTMX vs IDN Comparison
CTMX vs IDN Comparison
Compare CTMX & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- IDN
- Stock Information
- Founded
- CTMX 2008
- IDN 1994
- Country
- CTMX United States
- IDN United States
- Employees
- CTMX N/A
- IDN N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- IDN Computer Software: Prepackaged Software
- Sector
- CTMX Health Care
- IDN Technology
- Exchange
- CTMX Nasdaq
- IDN Nasdaq
- Market Cap
- CTMX 60.1M
- IDN 46.8M
- IPO Year
- CTMX 2015
- IDN 1999
- Fundamental
- Price
- CTMX $1.09
- IDN $2.79
- Analyst Decision
- CTMX Buy
- IDN Buy
- Analyst Count
- CTMX 5
- IDN 2
- Target Price
- CTMX $5.52
- IDN $3.00
- AVG Volume (30 Days)
- CTMX 1.7M
- IDN 46.8K
- Earning Date
- CTMX 05-12-2025
- IDN 05-13-2025
- Dividend Yield
- CTMX N/A
- IDN N/A
- EPS Growth
- CTMX N/A
- IDN N/A
- EPS
- CTMX 0.38
- IDN N/A
- Revenue
- CTMX $138,103,000.00
- IDN $19,997,000.00
- Revenue This Year
- CTMX N/A
- IDN $7.60
- Revenue Next Year
- CTMX N/A
- IDN $10.02
- P/E Ratio
- CTMX $2.89
- IDN N/A
- Revenue Growth
- CTMX 36.45
- IDN 5.77
- 52 Week Low
- CTMX $0.40
- IDN $1.92
- 52 Week High
- CTMX $2.81
- IDN $4.46
- Technical
- Relative Strength Index (RSI)
- CTMX 77.87
- IDN 60.12
- Support Level
- CTMX $0.63
- IDN $2.47
- Resistance Level
- CTMX $1.04
- IDN $2.87
- Average True Range (ATR)
- CTMX 0.10
- IDN 0.17
- MACD
- CTMX 0.04
- IDN 0.03
- Stochastic Oscillator
- CTMX 82.43
- IDN 85.96
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.